- Rating
- 3(+1)
- Confidence
- 3
- Informativeness
- 2
- Presentation
- 2
- Soundness
- 2
Read review
Paper summary
The authors propose DARA, a pancreatic tumor segmentation model that uses deviation from normal anatomy as extra evidence, with two components: SAG, which learns a normal anatomy model from tumor-free CTs and turns a patient's deviation from it into a voxel-level map, and BRR, which fuses the CT-only and SAG-aware predictions through a bounded logit correction. Experiments on PanTSMini, MSD07, and PANORAMA demonstrate DSC gains of 3.96%, 3.86%, and 0.66% over the second-best of ten segmentation baselines.
Critical strengths
- The motivation is clear and makes clinical sense. Comparing a patient's anatomy with a learned normal reference is a natural way to add evidence when the tumor itself is hard to see.
- The evaluation is extensive. It covers 2 datasets, including a large PanTS subset, and 10 recent segmentation baselines.
- The bounded residual design helps keep the final output anchored to the CT-only prediction and limits how much the deviation branch can change it.
Critical weaknesses
- Need more ablation. Most of the gain comes from fusing two models. A simple max of the two branches (36.54) already beats every baseline. Please run BRR on two CT-only nnU-Nets.
- The comparison is unfair. DARA uses extra reference CTs, organ labels, and 13 trained nnU-Nets, while each baseline is a single network trained on tumor labels only.
- Anatomy-aware baselines are missing, such as "Position-Aware Representation Learning with Anatomical Priors for Enhanced Pancreas Tumor Segmentation" (Dong et al., Neurocomputing 2025), which the authors cite but do not compare against.
Questions for authors
- BRR only corrects the tumor logit, so DARA's pancreas output should come from one of the two branches. Yet its pancreas results in Table 10 differ from nnU-Net's (e.g., 84.58 vs. 84.32 DSC on PanTSMini, 93.97 vs. 93.22 on PANORAMA). Which model produces DARA's pancreas mask? Is the CT-only branch the same model as the nnU-Net baseline in Table 1?
- How were the deviation weights (w_n, w_r, w_s, w_a) = (0.25, 0.75, 0.25, 1.0) chosen?
2 comments
3. Pancreas-output construction
Thank you for pointing out this ambiguity. BRR applies the bounded residual correction to the CT-only tumor logit. The CT-only branch itself is the same trained nnU-Net used as the Table 1 baseline. The final multiclass output is subsequently constructed using the refined tumor prediction together with the pancreas prediction, so the reported final pancreas mask can differ slightly from the original CT-only pancreas output.
Accordingly, the pancreas DSC changes from 84.32 to 84.58 on PanTSMini, 85.78 to 85.79 on MSD07, and 93.22 to 93.97 on PANORAMA. These differences reflect the final multiclass output construction rather than a separately trained CT-only model or a direct residual correction to the pancreas logit.
The revised manuscript now states the BRR output and final multiclass construction more explicitly.
4. Deviation-weight selection and sensitivity
The deviation weights were selected from a small set of candidate configurations on the PanTSMini validation set and then fixed across all three datasets without further tuning. The selected configuration is
We additionally evaluate several alternative configurations while keeping all other components unchanged:
| DSC | NSD | Recall | |
|---|---|---|---|
| 37.47 | 33.15 | 46.58 | |
| 38.21 | 34.02 | 48.01 | |
| 36.23 | 33.48 | 46.80 | |
| 37.93 | 33.76 | 46.26 |
The selected configuration performs best among the tested settings, while the alternatives remain competitive. The same weights are used unchanged on MSD07 and PANORAMA.
We sincerely thank the reviewer again for the constructive suggestions. The additional CT+CT control, matched anatomy-aware comparison, and implementation clarifications have substantially strengthened the evaluation. We hope these additions have adequately addressed the reviewer’s main concerns, and we would be deeply grateful if the reviewer could kindly reconsider the current rating.
We sincerely thank the reviewer for the careful and constructive comments. The suggestions helped us better separate the contribution of structural deviation from generic model fusion and clarify the resource, anatomy-aware comparison, and implementation issues. All newly added or revised content in the manuscript is highlighted in blue for ease of review.
1. Contribution beyond generic two-model fusion
The strong maximum-fusion result (36.54 DSC) makes generic model diversity an important alternative explanation. Following the reviewer’s suggestion, we therefore evaluate two independently trained CT-only nnU-Nets with the same architecture, training data, supervision, and schedule, differing only in random seed. Their OOF predictions are used to train the same BRR refiner.
The CT+CT control improves recall but remains substantially below DARA. Maximum fusion shows the same pattern: combining two CT-only models produces almost no DSC gain, whereas CT+SAG reaches 36.54 DSC. This indicates that generic model diversity alone does not reproduce the benefit obtained when one branch receives patient-to-normal structural-deviation information.
The matched AG+BRR control provides a complementary comparison. It retains the anatomy predictor, anatomical supervision, second segmentation branch, OOF procedure, and BRR, while removing only the structural-deviation input. DARA improves over AG+BRR by +4.61/+3.86/+8.26 pp in DSC/NSD/Recall. For each subject, we first average the metric across the three random seeds for each method and then perform a 10,000-sample paired bootstrap over subjects. The resulting 95% CIs are [+3.110,+6.179], [+2.259,+5.562], and [+6.290,+10.340], respectively.
We further include EmpiricalRef+BRR to separate access to the reference cohort from optimized structured-reference modeling. It uses the same reference subjects, frozen node encoder, K=4 states, and the same SAG-aware/OOF/BRR pipeline, but replaces the optimized reference with K-means prototypes and empirical shape/relation averages. EmpiricalRef+BRR obtains 34.62 DSC, compared with 38.21 DSC for DARA.
Together, these controls distinguish generic two-model diversity, access to anatomical/reference resources, and the proposed optimized patient-to-normal structural-deviation modeling.
2. Resource comparability and anatomy-aware comparison
DARA uses additional anatomical information and additional training-time computation relative to a single segmentation network. Accordingly, Table 1 is described as an end-to-end system-level comparison, while the matched controls above are used for methodological attribution.
The 5-fold OOF models are used only to generate held-out predictions for BRR training and are discarded afterwards; they are not ensembled at inference. At test time, DARA uses one frozen anatomy predictor, one CT-only branch, one SAG-aware branch, and the lightweight BRR refiner.
The reference cohort is used only to construct the NAU, which is subsequently frozen, while organ annotations are used only to train the frozen anatomy predictor. These resources therefore provide additional anatomical knowledge rather than additional tumor-supervised segmentation cases.
We also add the anatomy-aware comparison suggested by the reviewer. We implement the position-aware anatomical-prior baseline under the same predefined split, nnU-Net backbone, available anatomical supervision, validation-based model selection, and three-seed evaluation protocol as DARA.
Under this matched evaluation, DARA achieves the strongest overall performance.